Abstract
ARPE-19 and Y79 cells were precisely and effectively delivered to form an in vitro retinal tissue model via 3D cell bioprinting technology. The samples were characterized by cell viability assay, haematoxylin and eosin and immunofluorescent staining, scanning electrical microscopy and confocal microscopy, and so forth. The bioprinted ARPE-19 cells formed a high-quality cell monolayer in 14 days. Manually seeded ARPE-19 cells were poorly controlled during and after cell seeding, and they aggregated to form uneven cell layer. The Y79 cells were subsequently bioprinted on the ARPE-19 cell monolayer to form 2 distinctive patterns. The microvalve-based bioprinting is efficient and accurate to build the in vitro tissue models with the potential to provide similar pathological responses and mechanism to human diseases, to mimic the phenotypic endpoints that are comparable with clinical studies, and to provide a realistic prediction of clinical efficacy.
Original language | English |
---|---|
Pages (from-to) | 1297-1306 |
Number of pages | 10 |
Journal | Journal of Tissue Engineering and Regenerative Medicine |
Volume | 12 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2018 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:Copyright © 2018 John Wiley & Sons, Ltd.
ASJC Scopus Subject Areas
- Medicine (miscellaneous)
- Biomaterials
- Biomedical Engineering
Keywords
- age-related macular degeneration (AMD)
- bioprinting
- retina
- retinoblastoma
- tissue model